REPLIGEN CORP

RGEN - Company ID 0000730272

Market cap$8.12 B

Rank#1079

Filings1,331

REPLIGEN CORP has filed 1,331 public company documents between 1995 and 2026. The most frequent type is insider trade (594 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchRGEN overview$8.12 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1079See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut RGEN beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow RGEN via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

MRNAModerna, Inc.

BIIBBiogen Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
ARS	Annual report to shareholders	3mo ago2026-04-02	2025-12-31	View filing
ARS	Annual report to shareholders	1y ago2025-04-04	2024-12-31	View filing
ARS	Annual report to shareholders	2y ago2024-04-01	2023-12-31	View filing
ARS	Annual report to shareholders	3y ago2023-04-11	2022-12-31	View filing
ARS	Annual report to shareholders	12y ago2014-04-08	2013-12-31	View filing
ARS	Annual report to shareholders	17y ago2008-08-18	2008-03-31	View filing
ARS	Annual report to shareholders	21y ago2004-08-03	2004-03-31	View filing
ARS	Annual report to shareholders	23y ago2002-08-07	2002-03-31	View filing

REPLIGEN CORP

Similar companies to research next

Year